Changsha Sidian Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Changsha Sidian Technology Co., Ltd holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 28 (Toys & Sporting Goods) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DEEMEN, WEANKE, and BIONWEAL. The owner is based in Changsha City, Hunan.
Building B5, Lugu Enterprise Square
Yuelu District
Changsha City, Hunan 410000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Changsha Sidian Technology Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Changsha Sidian Technology Co., Ltd have?
Changsha Sidian Technology Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Changsha Sidian Technology Co., Ltd file in?
Changsha Sidian Technology Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 28 (Toys & Sporting Goods), Class 25 (Clothing), Class 10 (Medical Apparatus). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.
What are Changsha Sidian Technology Co., Ltd's most well-known trademarks?
Changsha Sidian Technology Co., Ltd's registered trademark portfolio includes well-known marks such as DEEMEN, WEANKE, and BIONWEAL. These are among 3 currently registered trademarks in the portfolio.
What is Changsha Sidian Technology Co., Ltd's trademark registration success rate?
Changsha Sidian Technology Co., Ltd has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.